GLP-1 release in man after lower large bowel resection or intrarectal glucose administration

Digestion

Volumn 59, Issue 6, 1998, Pages 689-695

  Printz, H ^a   Reiter, S ^a   Samadi, N ^a   Ebrahimsade, S ^a   Kirchner, R ^b   Arnold, R ^a   Goke B ^a,c  

^a Clin Res U Gastrointest E   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

Glucagon like peptide 1; Intrarectal glucose; Rectum resection; Sigmoid colon resection

Indexed keywords

C PEPTIDE; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE;

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TRANSPORT; HUMAN; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RECTUM RESECTION; SIGMOIDECTOMY;

ADMINISTRATION, RECTAL; ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; COLON, SIGMOID; ENEMA; FEMALE; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; HUMANS; INSULIN; INTESTINE, LARGE; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PROTEIN PRECURSORS; RECTAL DISEASES; RECTUM; SIGMOID DISEASES;

EID: 0031795303     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000007577     Document Type: Article

References (19)

1. Creutzfeldt W, Nauck M: Gut hormones and diabetes mellitus. Diabetes Metab Rev 1992;8: 149-177.
2. Kolligs F, Fehmann HC, Göke R, Göke B: Reduction of the incretin effect in rats by the glucagon-like peptide-1 receptor antagonist exendin (9-39) amide. Diabetes 1995;44:16-19.
3. Herrmann C, Göke R, Richter G, Fehmann HC, Arnold R, Göke B: Glucagon-like peptide 1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients. Digestion 1995;56:117-126.
4. Schirra J, Katschinski M, Weidmann C, Schäfer T, Wank U, Arnold R, Göke B: Gastric emptying and release of incretin hormones after glucose ingestion in humans. J Clin Invest 1996;97:92-103.
5. Eissele R, Göke R, Willemer S, Harthus HP, Vermeer H, Arnold R, Göke B: Glucagon-like peptide 1 (7-36) amide cells in the gastrointestinal tract and pancreas of rat, pig and man. Eur J Clin Invest 1992;22:283-291.
6. Brubaker PL: Release of GLP-1 into the circulation; in Fehmann H-G, Göke B (eds): The Insulinotropic Gut Hormone Glucagon-Like Peptide-1. Front Diabetes. Basel, Karger, 1997, vol 13, pp 65-84.
7. Göke B, Herrmann C, Göke R, Fehmann HC, Berghöfer P, Richter G, Arnold R: Intestinal effects of α-glucosidase inhibitors: Absorption of nutrients and enterohormonal changes. Eur J Clin Invest 1994;24:25-30.
8. Göke B, Fuder H, Wieckhorst G, Theiss U, Stridde E, Littke T, Kleist P, Arnold R, Lücker PW: Voglibose (AO-128) is an efficient α-glucosidase inhibitor and mobilizes the endogenous GLP-1 reserve. Digestion 1995;56:493-501.
9. Reimer RA, McBurney MI: Dietary fiber modulates intestinal proglucagon messenger ribonucleic acid and postprandial secretion of glucagon-like peptide-1 and insulin in rats. Endocrinology 1996;137:3948-3956.
10. Lauritsen KB, Moddy AJ, Christensen KC, Lindkaer Jensen S: Gastric inhibitory polypeptide (GIP) and insulin release after small-bowel resection in man. Scand J Gastroenterol 1980; 15:833-840.
11. Nauck MA, Siemsglüss J, Orskov C, Holst JJ: Release of glucagon-like peptide 1 (GLP-1) [7-36 amide], gastric inhibitory polypeptide [GIP] and insulin in response to oral glucose after upper and lower intestinal resections. Z Gastroenterol 1996;34:159-166.
12. Palnaes Hansen C, Andreasen JJ, Holst JJ: The release of gastric inhibitory peptide, glucagon-like peptide-I, and insulin after oral glucose test in colectomized subjects. Scand J Gastroenterol 1997;32:473-477.
13. Barros D'Sa AAB, Buchanan KD: Role of gastrointestinal hormones in the response to massive resection of the small bowel. Gut 1977;18: 877-881.
14. Nauck MA, Holst JJ, Willms B, Schmiegel W: Glucagon-like peptide 1 (GLP-1) as a new therapeutic approach for type 2-diabetes. Exp Clin Endocrinol Diabetes 1997;105:187-195.
15. Lebovitz HE: Alpha-glucosidase inhibitors. Endocrinol Metab Clin North Am 1997;26:539-550.
16. Qualmann C, Nauck MA, Holst JJ, Orskov C, Creutzfeldt W: Glucagon-like peptide-1 (7-36 amide) secretion in response to luminal sucrose from the upper and lower gut. A study using α-glucosidase inhibition (acarbose). Scand J Gastroenterol 1995;30:892-896.
17. Göke B, Kleist P, Littke T, Stridde E, Haupt E: Effects of voglibose and acarbose on glucose homeostasis and glucagon-like peptide-1 secretion in NIDDM patients (abstract). Diabetologia 1997;40:130.
18. Herrmann-Rinke C, Eissele R, Arnold R, Göke B: Studies on the viability of the isolated vascularly perfused rat colon. Digestion 1996;57: 349-355.
19. Hörsch D, Fink T, Göke B, Arnold R, Büchler M, Weihe E: Distribution and chemical phenotypes of neuroendocrine cells in the human anal canal. Regul Pept 1994;54:527-542.